Identification of a Small-Molecule Entry Inhibitor for Filoviruses
- 1 April 2011
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 85 (7), 3106-3119
- https://doi.org/10.1128/jvi.01456-10
Abstract
Ebola virus (EBOV) causes severe hemorrhagic fever, for which therapeutic options are not available. Preventing the entry of EBOV into host cells is an attractive antiviral strategy, which has been validated for HIV by the FDA approval of the anti-HIV drug enfuvirtide. To identify inhibitors of EBOV entry, the EBOV envelope glycoprotein (EBOV-GP) gene was used to generate pseudotype viruses for screening of chemical libraries. A benzodiazepine derivative (compound 7) was identified from a high-throughput screen (HTS) of small-molecule compound libraries utilizing the pseudotype virus. Compound 7 was validated as an inhibitor of infectious EBOV and Marburg virus (MARV) in cell-based assays, with 50% inhibitory concentrations (IC50s) of 10 μM and 12 μM, respectively. Time-of-addition and binding studies suggested that compound 7 binds to EBOV-GP at an early stage during EBOV infection. Preliminary Schrödinger SiteMap calculations, using a published EBOV-GP crystal structure in its prefusion conformation, suggested a hydrophobic pocket at or near the GP1 and GP2 interface as a suitable site for compound 7 binding. This prediction was supported by mutational analysis implying that residues Asn69, Leu70, Leu184, Ile185, Leu186, Lys190, and Lys191 are critical for the binding of compound 7 and its analogs with EBOV-GP. We hypothesize that compound 7 binds to this hydrophobic pocket and as a consequence inhibits EBOV infection of cells, but the details of the mechanism remain to be determined. In summary, we have identified a novel series of benzodiazepine compounds that are suitable for optimization as potential inhibitors of filoviral infection.Keywords
This publication has 65 references indexed in Scilit:
- A Small-Molecule Oxocarbazate Inhibitor of Human Cathepsin L Blocks Severe Acute Respiratory Syndrome and Ebola Pseudotype Virus Infection into Human Embryonic Kidney 293T cellsMolecular Pharmacology, 2010
- Antiviral Activity of a Small-Molecule Inhibitor of Filovirus InfectionAntimicrobial Agents and Chemotherapy, 2010
- Zaire Ebola virus entry into human dendritic cells is insensitive to cathepsin L inhibitionCellular Microbiology, 2010
- A Small-Molecule Dengue Virus Entry InhibitorAntimicrobial Agents and Chemotherapy, 2009
- Structure of the Ebola virus glycoprotein bound to an antibody from a human survivorNature, 2008
- Unique Small Molecule Entry Inhibitors of Hemorrhagic Fever ArenavirusesPublished by Elsevier BV ,2008
- Receptor determinants of zoonotic transmission of New World hemorrhagic fever arenavirusesProceedings of the National Academy of Sciences of the United States of America, 2008
- Complex of a Protective Antibody with Its Ebola Virus GP Peptide Epitope: Unusual Features of a Vλx Light ChainJournal of Molecular Biology, 2008
- Transferrin receptor 1 is a cellular receptor for New World haemorrhagic fever arenavirusesNature, 2007
- Tyro3 Family-Mediated Cell Entry of Ebola and Marburg VirusesJournal of Virology, 2006